These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 1788003)

  • 1. [Vaccinal measles process in children during the manifestations of acute respiratory diseases].
    Sergeeva MV; Vorotyntseva NV; Titova NS
    Pediatriia; 1991; (10):57-61. PubMed ID: 1788003
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological reactivity of children vaccinated with a live measles vaccine].
    Bolotovskiĭ VM; Titova NS; Zakharova TR; Vorotyntseva NV; Mushkova EM
    Vopr Virusol; 1983; 28(5):588-90. PubMed ID: 6659474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinico-immunological characteristics of the measles vaccine process in frequently ill children].
    Lakotkina EA; Zheleznikova GF; Blagoslovenskiĭ GS; Cherniaeva TV; Vozniuk TI
    Pediatriia; 1988; (1):48-51. PubMed ID: 3362610
    [No Abstract]   [Full Text] [Related]  

  • 4. [The immune response of children with an iron deficiency to vaccination with a live measles vaccine].
    Kazakova LM; Makrushin IM; Tsvetova GV; Arsent'eva TN; Shabaldin AV
    Pediatriia; 1992; (7-9):36-7. PubMed ID: 1475138
    [No Abstract]   [Full Text] [Related]  

  • 5. [Program for carrying out a campaign of controlled measles vaccination in a local area].
    Santoro R; Polo M; Rigoli E; Scardellato U; Annesi I; Grandolfo ME; Novello F
    Ann Ist Super Sanita; 1982; 18(3):441-4. PubMed ID: 7187830
    [No Abstract]   [Full Text] [Related]  

  • 6. Study of antibody titres after measles vaccination: fever within 7 days of vaccination and efficacy of booster doses.
    Egami T; Egami K; Tanoue A
    Arch Dis Child; 2008 Apr; 93(4):319-20. PubMed ID: 17488762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-measles humoral immunity in children with thymus hyperplasia].
    Gurvich EB; Lysenkova NV; Shishatskaia SN; Vaganov PD; Ozeretskovskiĭ NA
    Pediatriia; 1989; (9):31-3. PubMed ID: 2587164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and immunological reactions after measles vaccination with cleavage vaccine and live vaccine].
    Stehr K; Enders G; Suschke HJ; Spiess H
    Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):383-7. PubMed ID: 5523685
    [No Abstract]   [Full Text] [Related]  

  • 9. Sidestepping maternal antibody: a lesson from measles virus vaccination.
    Kim D; Niewiesk S
    Expert Rev Clin Immunol; 2011 Sep; 7(5):557-9. PubMed ID: 21895466
    [No Abstract]   [Full Text] [Related]  

  • 10. Rural Kenya: measles during pregnancy and early infancy.
    Arya SC; Agarwal N
    J Infect Dis; 2006 Jan; 193(1):165-6; author reply 166-7. PubMed ID: 16323147
    [No Abstract]   [Full Text] [Related]  

  • 11. [Means of improving measles vaccinal prophylaxis].
    Smorodintsev AA; Boĭchuk LM; Rykushin IuP; Smorodintsev AA
    Tr Inst Im Pastera; 1979; 53():12-9. PubMed ID: 162456
    [No Abstract]   [Full Text] [Related]  

  • 12. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
    Dilraj A; Sukhoo R; Cutts FT; Bennett JV
    Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunologic evaluation of measles vaccine in preschool and school children].
    Soto C; Cordero J; Vergara MI
    Rev Chil Pediatr; 1981; 52(6):491-5. PubMed ID: 7347862
    [No Abstract]   [Full Text] [Related]  

  • 14. [The HLA antigen system and the immune response in measles vaccination].
    Kharit SM; Kapralova MA
    Tr Inst Im Pastera; 1985; 62():72-5. PubMed ID: 3843366
    [No Abstract]   [Full Text] [Related]  

  • 15. Measles virus-specific IgG4 antibody titer as a serologic marker of post-vaccinal immune response.
    Isa MB; Martínez LC; Ferreyra LJ; Giordano MO; Barril PA; Massachessi G; Nates SV
    Viral Immunol; 2006; 19(2):335-9. PubMed ID: 16817776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunologic response and post-vaccination reactions in children vaccinated against measles. I. Assessment of post-vaccination reactions].
    Naruszewicz-Lesiuk D; Kańtoch M; Polna I
    Przegl Epidemiol; 1974; 28(3):315-24. PubMed ID: 4471837
    [No Abstract]   [Full Text] [Related]  

  • 17. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
    Dennehy PH; Saracen CL; Peter G
    Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Report of a workshop: disease accentuation after immunization with inactivated microbial vaccines.
    Craighead JE
    J Infect Dis; 1975 Jun; 131(6):749-54. PubMed ID: 1169271
    [No Abstract]   [Full Text] [Related]  

  • 19. [Possibilities of measles vaccination in children with counterindications and duration of preservation of postvaccinal immunity].
    Piriev GG; Liashchenko VA
    Pediatriia; 1990; (12):27-30. PubMed ID: 2075059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccination.
    Borràs E; Urbiztondo L; Costa J; Batalla J; Torner N; Plasencia A; Salleras L; Domínguez À;
    Epidemiol Infect; 2012 Sep; 140(9):1599-606. PubMed ID: 22074684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.